PR-018: An Open-Label, Safety Extension of Study PR-011

计划入组 15 人 · 首次发布于 2010 年 5 月 27 日

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

计划入组 165 人 · 首次发布于 2011 年 6 月 16 日

Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis

计划入组 50 人 · 首次发布于 2018 年 6 月 19 日

PR-001337

PR-000609

PR-21

JOLLC Gurabo, PR

United States

NOVIS PR LLC

United States

Praxis Precision Medicines

United States

Ryvu Therapeutics Provides Update on RVU120 Phase II Program

Karmanos Cancer Institute First to Prescribe FDA-Approved TheraBionic P1 for Advanced Liver Cancer

FDA Approves Alhemo for Hemophilia and alfapump System for Liver Cirrhosis